SIS 102 ACH
Alternative Names: SIS-102-ACHLatest Information Update: 20 Jan 2023
At a glance
- Originator SiSaf
- Class Small interfering RNA
- Mechanism of Action RNA interference; Type 3 fibroblast growth factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Achondroplasia
Most Recent Events
- 25 Nov 2022 Preclinical trials in Achondroplasia in United Kingdom (unspecified route) (Sisaf pipeline, November 2022)